JO3769B1 - علاج RNAi لعدوى فيروس التهاب الكبد B - Google Patents
علاج RNAi لعدوى فيروس التهاب الكبد BInfo
- Publication number
- JO3769B1 JO3769B1 JOP/2016/0170A JOP20160170A JO3769B1 JO 3769 B1 JO3769 B1 JO 3769B1 JO P20160170 A JOP20160170 A JO P20160170A JO 3769 B1 JO3769 B1 JO 3769B1
- Authority
- JO
- Jordan
- Prior art keywords
- hepatitis
- virus infection
- triggers
- rnai
- hbv
- Prior art date
Links
- 230000009368 gene silencing by RNA Effects 0.000 title abstract 5
- 108091030071 RNAI Proteins 0.000 title abstract 4
- 208000002672 hepatitis B Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 230000014509 gene expression Effects 0.000 abstract 3
- 241000700721 Hepatitis B virus Species 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562202253P | 2015-08-07 | 2015-08-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO3769B1 true JO3769B1 (ar) | 2021-01-31 |
Family
ID=59687542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOP/2016/0170A JO3769B1 (ar) | 2015-08-07 | 2016-08-04 | علاج RNAi لعدوى فيروس التهاب الكبد B |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR105611A1 (es) |
| JO (1) | JO3769B1 (es) |
| TW (2) | TWI761308B (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8501930B2 (en) * | 2010-12-17 | 2013-08-06 | Arrowhead Madison Inc. | Peptide-based in vivo siRNA delivery system |
| TWI695066B (zh) * | 2011-06-30 | 2020-06-01 | 美商艾羅海德製藥公司 | 用於抑制b型肝炎病毒基因表現之組合物及方法 |
-
2016
- 2016-08-04 JO JOP/2016/0170A patent/JO3769B1/ar active
- 2016-08-05 TW TW105125092A patent/TWI761308B/zh active
- 2016-08-05 TW TW110125844A patent/TWI794884B/zh not_active IP Right Cessation
- 2016-08-05 AR ARP160102399A patent/AR105611A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202142242A (zh) | 2021-11-16 |
| AR105611A1 (es) | 2017-10-18 |
| TW201717971A (zh) | 2017-06-01 |
| TWI794884B (zh) | 2023-03-01 |
| TWI761308B (zh) | 2022-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20170161A1 (ar) | عوامل RNAi للعدوى بفيروس التهاب الكبد ب | |
| WO2017027350A3 (en) | Rnai therapy for hepatitis b virus infection | |
| ZA202106265B (en) | Compositions and methods for inhibiting gene expression of lpa | |
| PH12017500614A1 (en) | Compositions and methods for silencing hepatitis b virus gene expression | |
| MX2022011756A (es) | Tratamiento combinado con un agonista de tlr7 y un inhibidor del ensamblaje de la capsida del vhb. | |
| PH12019550113A1 (en) | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus | |
| PH12014500724A1 (en) | Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication | |
| MX2021006635A (es) | Composiciones de acido ribonucleico de interferencia (arni) contra el virus de la hepatitis b (hbv) y metodos de uso de estas. | |
| PH12021551866A1 (en) | RNAi AGENTS FOR HEPATITIS B VIRUS INFECTION | |
| HK1248278A1 (zh) | 用於使乙型肝炎病毒基因表达沉默的组合物及方法 | |
| JOP20180008A1 (ar) | مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b | |
| MX371093B (es) | Compuestos de microarn y metodos para modular al mir-122. | |
| WO2016183366A3 (en) | Compositions and methods for silencing expression of hepatitis d virus rna | |
| MX2017014641A (es) | Composiciones y metodos para inhibir la expresion del gen de factor inducible por hipoxia alfa (hif2alfa). | |
| PH12014500385A1 (en) | Benzofuran compounds for the treatment of hepatitis c virus infections | |
| PH12018502320A1 (en) | Reagents for treatment of hepatitis b virus (hbv) infection and use thereof | |
| JO3769B1 (ar) | علاج RNAi لعدوى فيروس التهاب الكبد B | |
| TH1901000740A (th) | สาร rnai สำหรับการติดเชื้อไวรัสตับอักเสบ b | |
| EA201990427A1 (ru) | АГЕНТЫ РНКи ПРОТИВ ИНФЕКЦИИ, ВЫЗВАННОЙ ВИРУСОМ ГЕПАТИТА В | |
| AR109293A1 (es) | AGENTES DE iARN PARA LA INFECCIÓN POR EL VIRUS DE LA HEPATITIS B |